Soleus Capital Master Fund, L.P. 13D and 13G filings for Surmodics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-22 5:15 pm Purchase |
2025-01-21 | 13G | Surmodics, Inc. SRDX |
Soleus Capital Master Fund, L.P. | 739,060 5.200% |
101,362 (+15.89%) |
Filing |
| 2024-11-14 3:36 pm Sale |
2024-09-30 | 13G | Surmodics, Inc. SRDX |
Soleus Capital Master Fund, L.P. | 637,698 4.500% |
-134,002 (-17.36%) |
Filing |
| 2024-02-02 09:53 am Sale |
2023-12-31 | 13G | Surmodics, Inc. SRDX |
Soleus Capital Master Fund, L.P. | 771,700 5.400% |
-3,611 (-0.47%) |
Filing |
| 2023-02-14 08:16 am Purchase |
2022-12-31 | 13G | Surmodics, Inc. SRDX |
Soleus Capital Master Fund, L.P. | 775,311 5.500% |
61,347 (+8.59%) |
Filing |
| 2022-09-02 10:21 am Purchase |
2022-08-31 | 13G | Surmodics, Inc. SRDX |
Soleus Capital Master Fund, L.P. | 713,964 5.100% |
713,964 (New Position) |
Filing |